Home/Filings/4/0001214659-18-004880
4//SEC Filing

CHEN ISAN 4

Accession 0001214659-18-004880

CIK 0001576263other

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 7:00 PM ET

Size

11.4 KB

Accession

0001214659-18-004880

Insider Transaction Report

Form 4
Period: 2018-07-16
CHEN ISAN
Chief Medical & Dev't Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2018-07-16$17.41/sh+275$4,78832,111 total
  • Exercise/Conversion

    Common Stock

    2018-07-16$21.51/sh+1,592$34,24434,582 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2018-07-161,59225,908 total
    Exercise: $21.51Exp: 2025-02-03Common Stock (1,592 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2018-07-162755,913 total
    Exercise: $17.41Exp: 2024-05-20Common Stock (275 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    110
Footnotes (2)
  • [F1]Includes 879 shares acquired under the ESPP Purchase on 05/31/18.
  • [F2]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1
  • filerCIK 0001586218

Filing Metadata

Form type
4
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 7:00 PM ET
Size
11.4 KB